Skip to Content


In the US, Impavido (miltefosine systemic) is a member of the following drug classes: anthelmintics, miscellaneous antineoplastics and is used to treat Leishmaniasis.

US matches:

Ingredient matches for Impavido


Miltefosine is reported as an ingredient of Impavido in the following countries:

  • Ecuador
  • Germany
  • United States

International Drug Name Search

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.